Janina Krumbeck, PhD, discusses the clinical advantages of next-generation sequencing over traditional culture and how this untargeted diagnostic approach provides comprehensive pathogen ...

Based Platforms, Isothermal Amplification Technologies, and Lab-on-a-Chip Systems Accelerating Market Expansion Globally.Austin, United States, March 09, 2026 (GLOBE NEWSWIRE) -- Point-of-Care ...

Three-site reproducibility study completed by Tampa General Hospital, Mayo Clinic, and Baylor Scott & White HealthSufficient clinical samples ...

Expanding access to advanced PCR thermocyclers, DNA & RNA purification systems, and hematology analyzers for modern clinical ...

Opportunities lie in integrating advanced diagnostics and digital solutions, leveraging partnerships, and enhancing supply ...

When Domain Associates led Xagenic Inc.’s recent $20 million Series B, it marked the eighth diagnostics investment the firm had made with its $500 million eighth fund. The partners say they’ve ...

In the following sections, we highlight ethical concerns about early adoption of molecular diagnostic testing without solid evidence or guidelines and offer practical guidance for ethical ...

Marian Saka is a highly skilled Molecular Genetic Technologist currently working in Texas, bringing extensive expertise in molecular biology, cell biology, immunology, microbiology, and biochemistry.

Insight Molecular Diagnostics is back in focus after analysts updated their price target, with some now pointing to US$12 alongside a refreshed fair value estimate of US$8.33, previously US$7.00. That ...

This article is authored by Dr Kirti Chadha, chief scientific and innovation officer, Metropolis Healthcare Limited.

IMDX is trading in the middle of its 52-week range and above its 200-day simple moving average. Price change The price of IMDX shares has decreased $0.10 since the market last closed. This is a 1.74% ...